FDA Expands Approval of GSKs Respiratory Syncytial Virus Vaccine

Compartió un vínculo

2026-03-13 16:00:05

The logo of the British multinational pharmaceutical company GlaxoSmithKline on top of its headquarters in London on Feb. 2, 2022. Justin Tallis/AFP via Getty ImagesU.S. regulators have expanded the approval

0 Commentarios 0 Acciones 22 Views